Domain-specific quantification of prion protein in cerebrospinal fluid by targeted mass spectrometry
Minikel, E.V.; Kuhn, E.; Cocco, A.R.; et al.
Accurate and reliable quantitation of prion protein (PrP) is necessary in prion disease therapeutics. Considering the potential challenges of current quantitative methods (e.g., inability to capture protein fragments), Carr and colleagues developed an alternative approach. This involved the quantitation of PrP in cerebrospinal fluid (CSF) by bottom-up LC-MRM-MS using uniform 15N-labeled PrP (expressed using CGM-1000-N) as an internal standard for human sample analysis and 13C/15N PrP tryptic peptides (synthesized using protected amino acids) for human and other species sample analyses. The metrics of the validated assay enable the selective and precise quantitation of CSF PrP and provides a basis for its clinical translation in support of on-going PrP-lowering drug studies.
Articles
- TMTpro: Design, synthesis, and initial evaluation of a proline-based isobaric 16-plex tandem mass tag reagent set
- Domain-specific quantification of prion protein in cerebrospinal fluid by targeted mass spectrometry
- A novel stable isotope tracer method to simultaneously quantify skeletal muscle protein synthesis and breakdown
- Impact of enteral arginine supplementation on lysine metabolism in humans: A proof-of-concept for lysine-related inborn errors of metabolism
- Identification of bioactive metabolites using activity metabolomics
